Thrombin inhibitors from different animals

Area of Science:

• Biochemistry
• Pharmacology
• Veterinary Medicine

Background:

• Thromboembolic diseases remain leading causes of death and disability in high-income nations.
• Current anticoagulants target coagulation enzymes like thrombin and factor Xa.
• Thrombin plays a critical role in clot formation by activating platelets and converting fibrinogen to fibrin.

Purpose of the Study:

• To summarize existing and emerging research on specific thrombin inhibitors found in various animal species.
• To explore the potential of these animal-derived inhibitors as novel antithrombotic therapies.

Main Methods:

• Literature review of scientific publications on thrombin inhibitors in animals.
• Analysis of the biochemical mechanisms and antithrombotic potential of identified inhibitors.

Main Results:

• Thrombin is a validated target for anticoagulant drug development.
• Selective thrombin inhibitors represent a promising class of antithrombotic agents.
• Various animal species possess specific thrombin inhibitors with potential therapeutic applications.

Conclusions:

• Specific thrombin inhibitors from animals warrant further investigation for antithrombotic drug development.
• Understanding these natural inhibitors could lead to new strategies for managing thromboembolic disorders.